Chandra Bhagat Pharma Limited (BOM:542934)

Chandra Bhagat Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 13, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	376	230	395	717	732	859
Market Cap Growth	-9.27%	-41.72%	-44.92%	-2.06%	-14.76%	187.37%
Enterprise Value	494	416	593	882	926	1,079
Last Close Price	49.90	30.50	52.33	95.00	97.00	113.80

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 13, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	12.36	7.56	46.03	46.84	80.83	107.77
PS Ratio	0.32	0.20	0.44	0.32	0.61	0.91
PB Ratio	1.14	0.70	1.32	2.47	2.66	3.22
P/TBV Ratio	1.14	0.70	1.32	2.47	2.66	3.22
P/FCF Ratio	4.53	2.77	-	18.41	14.95	6.98
P/OCF Ratio	4.08	2.49	-	11.61	13.90	6.93

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 13, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	0.42	0.36	0.65	0.40	0.77	1.15
EV/EBITDA Ratio	10.42	8.77	19.08	24.14	24.51	20.93
EV/EBIT Ratio	13.31	11.20	26.65	27.85	25.25	21.09
EV/FCF Ratio	5.94	5.00	-	22.66	18.91	8.77

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 13, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.50	0.50	0.70	0.57	0.69	0.79
Debt / EBITDA Ratio	3.48	3.48	6.72	4.49	5.02	4.10
Debt / FCF Ratio	1.99	1.99	-	4.22	3.87	1.72
Net Debt / Equity Ratio	0.35	0.35	0.67	0.39	0.45	0.57
Net Debt / EBITDA Ratio	2.48	2.48	6.46	3.10	3.28	2.95
Net Debt / FCF Ratio	1.41	1.41	-2.90	2.91	2.53	1.24
Asset Turnover	1.19	1.19	0.89	2.74	1.80	1.30
Inventory Turnover	34.94	34.94	15.69	11.03	3.38	2.35
Quick Ratio	1.02	1.02	0.53	0.63	0.55	0.55
Current Ratio	1.50	1.50	1.37	1.38	2.16	1.86
Return on Equity (ROE)	9.66%	9.66%	2.91%	5.42%	3.34%	3.03%
Return on Assets (ROA)	2.37%	2.37%	1.37%	2.44%	3.44%	4.43%
Return on Invested Capital (ROIC)	5.92%	5.59%	3.52%	4.73%	5.75%	8.02%
Return on Capital Employed (ROCE)	10.40%	10.40%	6.90%	10.30%	10.90%	14.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 13, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	8.09%	13.24%	2.17%	2.14%	1.24%	0.93%
FCF Yield	22.09%	36.13%	-17.51%	5.43%	6.69%	14.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 22, 2026

Data Sources Report a data error